Robotic upper-limb rehab vs standard therapy for adults with tetraplegia
Official title: Efficacy of Robotic Upper Limb Rehabilitation Training in Patients With Tetraplegia (TRRAT): A Pilot, Multicenter, Randomized Controlled Trial
Run by IRCCS Sacro Cuore Don Calabria di Negrar · NCT07860827 · Data updated 2026-11-12
This study tests whether a robotic arm rehabilitation device (PABLO®) plus standard therapy helps people with tetraplegia recover more upper-limb strength than standard rehab alone.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 24 (estimated) |
| Sponsor | IRCCS Sacro Cuore Don Calabria di Negrar Academic / other |
| Locations | 1 site (Negrar, Veneto) |
| Status | Recruiting |
| Started | April 1, 2024 |
| Main results expected | October 1, 2027 |
| Study ends | October 31, 2027 |
| Registry record updated | October 6, 2026 |
| Trial ID | NCT07860827 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–80 with tetraplegia/tetraparesis from spinal cord injury, able to move against gravity in at least one scapulohumeral or elbow muscle group, and within 120 days of injury.
✕Probably not a fit
Participants who do not show sufficient motor strength gains or who cannot tolerate the robotic device may experience no additional benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
In adults with tetraplegia from spinal cord injury, the trial compares two 3-week training approaches after an initial standard upper-limb rehab period. One group uses a robotic rehabilitation device (PABLO®) for the upper limb, while the other continues with standard physiotherapy. Assessments include the ASIA Impairment Scale for neurological status and the MRC scale for proximal upper-limb strength, with evaluations at baseline, after the standard rehab period, after the training phase, and at the end of the study. Participants are randomized after a 2–4 week hospitalization and must meet specific motor and stability criteria.
Why it matters
Potential benefit: If successful, the robotic approach could enhance proximal upper-limb strength and improve functional recovery for people with tetraplegia.
How similar studies have gone: Similar robotic rehabilitation approaches have shown promise in related spinal cord injury rehab settings, but this exact protocol is novel in its randomized comparison.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. PRIMARY * The investigator obtains the patient's informed consent to participate in the clinical trial and to the processing of personal data. * Tetraplegic/tetraparetic patients with spinal cord injury of various etiologies (traumatic, ischemic, infectious, etc.) as defined by the ASIA Impairment Scale, who are capable of movements at least against gravity-even with a partial range of motion (MRC ≥2/5)-in the muscles of the scapulohumeral region and the elbow on at least one side of the body. * Age ≥ 18 years and ≤ 80 years. * Time interval between the acute event and study enrollment not exceeding 120 days. 2. SECONDARY * Ability to maintain a seated position in a non-reclined wheelchair (trunk-pelvis angle of 90°) for one hour. * Improvement in strength of ≥ 1 point (out of 5) on the MRC scale in less than half of the upper limb regions assessed at Visit V1. Exclusion Criteria: * ASIA with a neurological level of C2 or higher. * Previous cerebrovascular events, neurodegenerative disorders, or spinal cord injuries that have resulted in motor and/or cognitive impairment. * History of major psychiatric disorders. * Concurrent traumatic brain injury during the acute phase. * Previous orthopedic conditions of the shoulder resulting in severe functional impairment. * Active rheumatological conditions. * Severe uncorrected visual impairment (such that it prevents the patient from viewing the computer-based exercises proposed by the robot).
Where it's running
-
IRCCS Sacro Cuore Don Calabria Hospital
Negrar, Veneto, Italy Recruiting
Study contacts
- Study coordinator: Elvia Malo, Dr.ssa
- Email: ricerca.clinica@sacrocuore.it
- Phone: +39 045.6014877
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Implanted Brain-Computer Interface to Help People with Severe Arm Impairment
We’re testing the N1 System, a fully implanted brain interface in the motor cortex with a robot, to see if it can help adults with spinal cord injury, ALS, or chronic stroke use a computer or keyboard more easily.
-
Wireless implant for brain-computer interface in people with tetraplegia from spinal cord injury
This trial tests a wireless brain-computer interface implanted in adults with tetraplegia to see if it is safe and if it can help restore some function.
-
Implanted brain interface to let people with severe paralysis control assistive devices
It will try an implanted brain interface that records and stimulates brain signals so adults with severe paralysis can control assistive devices and receive sensory feedback.
-
Connexus® Brain-Computer Interface to restore communication and device control
This study will try the Connexus brain-computer interface to help people with severe loss of voluntary movement (for example from ALS, cervical spinal cord injury, or stroke) communicate and control computers.
-
Robotic implantation of a precise brain‑computer interface to restore communication
This project tests whether a robotically implanted Neuralink N1 brain implant can help adults with severe, irreversible speech loss from ALS, spinal cord injury, or stroke communicate again.
-
Robotically implanted Neuralink N1 brain-computer interface to control external devices
This study will test whether a robotically implanted Neuralink N1 brain-computer interface can safely help people with high spinal cord injuries or ALS control computers and other external devices.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.